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1. Introduction
Severe combined immunodeficiency (SCID) comprises a group
of genetic disorders characterized by impaired cellular and
humoral immunity due to a block in T lymphocyte differenti-
ation, variably associated to abnormal development of other
lymphocyte lineage. The estimated incidence is 1 in 75,000–
100,000 births. It is characterized by early onset infections
that can be caused by low-virulence pathogens [1]. Sponta-
neous engraftment of maternal T‐cells through transplacental
transfer occurs in approximately 50% of the cases, and is
mostly asymptomatic [1,2]. The most common curative
therapy for all forms of SCID is hematopoietic stem cell
transplantation (HSCT) [3]. Without immune reconstitution,
SCID is inexorably fatal, mostly within the first year of life [4].
Benign monoclonal or polyclonal gammopathies and
lymphoprolipherative diseases have been described in malig-
nancies, auto-immune diseases, aplastic anemia and after
HSCT in patients with primary or secondary immunodefi-
ciencies. It is thought that they are secondary to monoclonal
B‐cell proliferation, as a consequence of an abnormal
regulatory T‐cell function [5–7].
In SCID patients, there is only one case report of monoclonal
IgA gammopathy prior to HSCT in a T-B‐SCID with maternal
B-lymphocyte engraftment, and uncontrolled proliferation [4].
To our knowledge, this is the first published case of an
infant with T-B+NK‐SCID (X-linked) who developed a mono-
clonal IgGK gammopathy derived from self B‐cells prior to HCT
that completely resolved after HCT when full engraftment of
donor T-cells occurred.2. Case report
A 17-days-old boy was admitted to a 3rd level Hospital near
Lisbon, due to an upper respiratory tract infection for which he
completed 7 days of erythromycin. Moraxella catharralis was1521-6616/$ - see front matter © 2012 Elsevier Inc. All rights reserved.
http://dx.doi.org/10.1016/j.clim.2012.08.011isolated in blood cultures. The differential leukocyte count
demonstrated severe lymphopenia (700 cells/μL). The child
was born at term by an uncomplicated, spontaneous vaginal
delivery. The birth weight and head circumference were on
50th percentile and length on 25th percentile. The child was
vaccinated at birth with bacilli Calmette Guérin and anti
Hepatitis-B-Virus vaccines. He is the second child of non-
consanguineous parents and has a healthy four years-old sister.
Three weeks later he was readmitted for fever and respira-
tory distress. His leukocyte count was: 17,900 leukocytes/μL,
of which 2600 lymphocytes/μL. Prompt antibiotherapy with
vancomycin and gentamicin was initiated. The chest X-ray
showed bilateral interstitial fullness and absence of thymic
shadow. The immunological evaluation led to a presumptive
diagnosis of SCID (Table 1), later genetically characterized
(hemizygous for G→A mutation at positioning 98 exon 5,
leading to a Cys231Tyr amino acid substitution in the common
cytokine gamma chain protein).
Chimerism studies were performed to assess for the
presence of exogenous maternal lymphocytes. The results
confirmed that 90% of T‐cells were of maternal origin, and
that all the B‐cells were self (Table 1).
He started prophylaxis with cotrimoxazol, fluconazol,
isoniazid, rifampicin and ethambutol, as well as regular
infusions of intravenous human immunoglobulin (IVIG), while
waiting for HSCT. Due to high levels of IgG, along with the
appearance of a monoclonal peak in the protein electropho-
resis, the presence of a B‐cell clone was suspected. The
immunofixation confirmed the presence of a monoclonal IgG
Kappa fraction (Table 1) resulting from an expansion of the
patient's B lymphocyte clone. Chimerism studies confirmed
the absence of maternal B‐cell engraftment. The viral load
of EBV and other viruses remained negative. The child was
submitted to HSCT from HLA-matched sibling donor without
conditioning at the age of 4 months.
There was full engraftment of the infused cells, with
complete immune reconstitution and no major complications
post-HSCT. Two months after HSCT, laboratory workout
revealed the disappearance of the previous gammopathy,
with polyclonal B‐cell population and normal serum immuno-
globulins (Table 1).3. Discussion
It is known that both primary and secondary immunodefi-
ciencies predispose to lymphoprolipherative disorders, gener-
ally of B‐cell origin [8].
Table 1 Laboratory tests results.








IgA (mg/dL) b8 b25 18 0–75
IgG (mg/dL) 121 914 970 660–1050
IgM (mg/dL) 19 206 95 50–220
Immunofixation Monoclonal IgG Kappa fraction –
Total Lymphocyte count 2500 7830 7450 3700–9000
CD3+(cells/μL) 102 6106 6513 2300–6500
CD3+CD4+(cells/μL) 88 763 2503 1500–5000
CD3+CD4+CD45RA (%) 1 11 72 64–92
CD3+CD8+(cells/μL) 0 5131 3664 500–1600
CD3+CD8+CD45RA (%) 0 6 11 53–88
CD16/56+(cells/μL) 35 544 491 100–1000
CD19+(cells/μL) 1750 1124 1384 600–1300
Lymphocyte proliferation
Phytohemagglutinin (SI) 0 40 51
PMA+ionomicin (SI) 0 52 63
PPD (SI) 0 70 20
Chimerism (locked in
T lymphocytes)
90% maternal 100% donor 100% donor








134 LETTER TO THE EDITORMonoclonal gammopathy [MG] in children is a rare disorder
that is defined as a monoclonal B-cell proliferative disorder
accompanied by an electrophoretically homogeneous immu-
noglobulin component (H-Ig) of a single isotype, allotype and
idiotype in the serum [8].
Benign gammopathies have been reported in several
conditions, such as hematological malignancies [8], autoim-
mune diseases [8], aplastic anemia [8], in bone marrow or
renal transplant recipients [5], or in patients with primary
immunodeficiencies, like SCID, auto-immune lymphopro-
liferative syndrome, Wiskott–Aldrich syndrome or ataxia–
telangiectasia [4,9].
Follow‐up analysis revealed that most of these MG were
transient [8]. Most cases of monoclonal or oligoclonal
gammopathies in infants with SCID occurred after HSCT,
before T-cell immune reconstitution was complete [4,10].
Mechanisms leading to gammopathy are speculative. The
hypothesis that diminution of T-cell mediated immune
surveillance might temporarily allow B-cell proliferation is
themost accepted and supported by animal experiments [4,8].As a rule, control would later be regained, with subsequent
stabilization or regression of the expanded clones [3].
Nevertheless, if control remained suppressed for a prolonged
period of time, progression to lymphoma or myeloma might
ensue [3,10]. Epstein–Barr virus may be responsible for the
activation and evolution of B‐cells into malignant monoclonal
B-cell lymphomas [3]. Normal B‐cell reconstitution post-HSCT
appears to be a recapitulation of normal ontogeny and an
impaired T-cell regulation may lead to an asynchronous,
clonally dysregulated reconstitution [3,10]. Clones which
recover faster than others can cause gammopathy, even
though the overall system remains controlled. These clones
are, most frequently, of donor origin [3]. To our knowledge,
there is only one published case of MG in children with SCID
previous to HSCT, and it was an IgA gammopathy, due to
maternal B‐cell engraftment and lack of T‐cell surveillance
[4].
In this report we describe a case ofmonoclonal gammopathy
of Ig G Kappa producing self B‐cells in a child with SCID previous
to HSCT. There was no evidence of malignancy nor EBV or
135LETTER TO THE EDITORother virus infections responsible for clonal activation.
Chimerism analysis demonstrated that all the B‐cells
belonged to the patient. The persistence of this B-cell
clone can be explained by the absence of normal T-cell
function regulating the proliferation and activation of this
B-cell clone, as described above. Restoration of T-cell
function by HSCT enabled the host to suppress this
aberrant B-cell proliferation, leading to spontaneous
resolution, as described in other case reports [4].Conflict of interest statement
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